Literature DB >> 1793043

Structural and functional organization of the human neutrophil 60 kDa bactericidal/permeability-increasing protein.

C E Ooi1, J Weiss, P Elsbach.   

Abstract

We have isolated, after limited proteolysis of the bactericidal/permeability-increasing protein (BPI) of human polymorphonuclear leukocytes (PMN), two fragments representing roughly the two halves of the BPI molecule. The 25 kDa N-terminal fragment possesses all the antibacterial activities of the 60 kDa parent protein, while the ca. 30 kDa C-terminal fragment has no detectable activity. The 25 kDa fragment is as potent on a molar basis as holo-human BPI against rough Escherichia coli, is more potent than holo-BPI against more resistant smooth E. coli, and retains the specificity of BPI toward Gram-negative bacteria. The findings suggest that all of the molecular determinants of the antibacterial properties of BPI reside within the N-terminal half of the molecule, implying a novel structural/functional organization for a cytotoxic protein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1793043     DOI: 10.1007/bf01993301

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  10 in total

Review 1.  Antibiotics from within: antibacterials from human and animal sources.

Authors:  P Elsbach
Journal:  Trends Biotechnol       Date:  1990-01       Impact factor: 19.536

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Antibiotic proteins of human polymorphonuclear leukocytes.

Authors:  J E Gabay; R W Scott; D Campanelli; J Griffith; C Wilde; M N Marra; M Seeger; C F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

4.  Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes.

Authors:  J Weiss; P Elsbach; I Olsson; H Odeberg
Journal:  J Biol Chem       Date:  1978-04-25       Impact factor: 5.157

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Separation of sublethal and lethal effects of the bactericidal/permeability increasing protein on Escherichia coli.

Authors:  B A Mannion; J Weiss; P Elsbach
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

7.  Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria. Implications and use as a means of purification.

Authors:  B A Mannion; E S Kalatzis; J Weiss; P Elsbach
Journal:  J Immunol       Date:  1989-04-15       Impact factor: 5.422

8.  Cloning of the cDNA of a human neutrophil bactericidal protein. Structural and functional correlations.

Authors:  P W Gray; G Flaggs; S R Leong; R J Gumina; J Weiss; C E Ooi; P Elsbach
Journal:  J Biol Chem       Date:  1989-06-05       Impact factor: 5.157

9.  A 25-kDa NH2-terminal fragment carries all the antibacterial activities of the human neutrophil 60-kDa bactericidal/permeability-increasing protein.

Authors:  C E Ooi; J Weiss; P Elsbach; B Frangione; B Mannion
Journal:  J Biol Chem       Date:  1987-11-05       Impact factor: 5.157

10.  Separation and purification of a potent bactericidal/permeability-increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes. Observations on their relationship.

Authors:  P Elsbach; J Weiss; R C Franson; S Beckerdite-Quagliata; A Schneider; L Harris
Journal:  J Biol Chem       Date:  1979-11-10       Impact factor: 5.157

  10 in total
  2 in total

1.  Antimicrobial activity of PLUNC protects against Pseudomonas aeruginosa infection.

Authors:  Lina Lukinskiene; Yang Liu; Susan D Reynolds; Chad Steele; Barry R Stripp; George D Leikauf; Jay K Kolls; Y Peter Di
Journal:  J Immunol       Date:  2011-06-01       Impact factor: 5.422

Review 2.  Antiendotoxin strategies for the prevention and treatment of septic shock. New approaches and future directions.

Authors:  S M Opal; R L Yu
Journal:  Drugs       Date:  1998-04       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.